Intravascular hemolysis following low dose daily rifampin

Cindy E. Neunert; Geeta S. Paranjape; Scott Cameron; Zora R. Rogers

doi:10.1002/pbc.21709

Intravascular hemolysis following low dose daily rifampin

Cindy E. Neunert, Geeta S. Paranjape, Scott Cameron, Zora R. Rogers

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.

Original language	English (US)
Pages (from-to)	821-823
Number of pages	3
Journal	Pediatric Blood and Cancer
Volume	51
Issue number	6
DOIs	https://doi.org/10.1002/pbc.21709
State	Published - Dec 2008
Externally published	Yes

Keywords

Anemia
Hemolysis
Rifampin

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.21709

Cite this

@article{2398da234c854de7856db346ffff9933,

title = "Intravascular hemolysis following low dose daily rifampin",

abstract = "We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.",

keywords = "Anemia, Hemolysis, Rifampin",

author = "Neunert, {Cindy E.} and Paranjape, {Geeta S.} and Scott Cameron and Rogers, {Zora R.}",

year = "2008",

month = dec,

doi = "10.1002/pbc.21709",

language = "English (US)",

volume = "51",

pages = "821--823",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "6",

}

TY - JOUR

T1 - Intravascular hemolysis following low dose daily rifampin

AU - Neunert, Cindy E.

AU - Paranjape, Geeta S.

AU - Cameron, Scott

AU - Rogers, Zora R.

PY - 2008/12

Y1 - 2008/12

N2 - We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.

AB - We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.

KW - Anemia

KW - Hemolysis

KW - Rifampin

UR - http://www.scopus.com/inward/record.url?scp=56749185819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749185819&partnerID=8YFLogxK

U2 - 10.1002/pbc.21709

DO - 10.1002/pbc.21709

M3 - Article

C2 - 18680155

AN - SCOPUS:56749185819

SN - 1545-5009

VL - 51

SP - 821

EP - 823

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 6

ER -

Intravascular hemolysis following low dose daily rifampin

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this